Summary & Overview
CPT 0529F: Specific CPT Service
Headline: CPT code 0529F: Specific CPT Service with Limited Public Description
Lead: CPT code 0529F is a Current Procedural Terminology entry with no publicly provided summary in the source input. The code denotes a specific billed clinical service whose detailed clinical description and common billing attributes were not included in the supplied data.
What the code represents and why it matters: As a CPT code, 0529F identifies a distinct reportable healthcare service used in claims and reimbursement workflows nationwide. Accurate identification and documentation of CPT codes are essential for claims processing, audit readiness, and clinical billing consistency across payers.
Key payers covered: Analysis references national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: This publication provides a concise reference for CPT code 0529F, highlights the absence of a supplied summary, and outlines the areas typically analyzed for billing codes: clinical context, sites of service, payer coverage patterns, and related coding considerations. Where specific fields are missing in the input, the text notes that the data are not available rather than substituting information.
Scope: The content is intended for a national audience of billing managers, clinicians involved in documentation, and payers seeking a quick reference to the code entry and the limitations of the provided description.
Billing Code Overview
CPT code 0529F has no summary available in the source description. Based on the code label, this entry represents a specific billed service under the Current Procedural Terminology (CPT) system.
-
Service type: Data not available in the input.
-
Typical site of service: Data not available in the input.
-
Description: No Summary found for this code
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a history of prior cancer treatment undergoing routine surveillance to document absence of disease or to monitor for recurrence. The patient presents to an outpatient radiology or nuclear medicine center for a PET/CT or PET imaging study that includes interpretation and reporting of whole-body radiotracer uptake patterns. The clinical workflow begins with an order placed by the treating oncologist or primary care provider, pre-procedure screening for contraindications (pregnancy, uncontrolled glucose for FDG PET), informed consent, radiotracer administration, uptake period, image acquisition on PET/CT, image processing, and formal interpretation by a board-certified nuclear medicine physician or radiologist. The study report includes assessment of metabolic activity at known primary tumor sites, regional nodes, and distant metastases, with comparison to prior imaging when available. Typical sites of service are outpatient hospital radiology departments, freestanding imaging centers, and hospital outpatient departments. Typical patient scenario: a middle-aged patient with history of treated lymphoma returns for surveillance PET/CT to evaluate for residual or recurrent metabolically active disease.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the interpretation/reporting professional component is billed separate from technical imaging services. |